All Companies

PCVXCongressional Stock Trades

Vaxcyte, Inc. Common Stock

Biological Products, (No Diagnostic Substances)

Congressional stock trades in Vaxcyte, Inc. Common Stock (PCVX) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

5

Politicians Trading

2

Last Traded

Jul 16, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Gilbert Ray Cisneros, Jr.DSep 4, 2026Jul 16, 2026Buy$1,001 - $15,000+3.73%
Gilbert Ray Cisneros, Jr.DMay 6, 2025Apr 28, 2025Buy$1,001 - $15,000+76.69%
Gilbert Ray Cisneros, Jr.DMay 6, 2025Apr 15, 2025Buy$1,001 - $15,000+92.29%
Gilbert Ray Cisneros, Jr.DMay 6, 2025Apr 14, 2025Buy$1,001 - $15,000+81.43%
Jefferson ShreveRApr 11, 2025Mar 5, 2025Sell$15,001 - $50,000-21.33%

Price History

About Vaxcyte, Inc. Common Stock

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.